{"date_created":"2012-05-08","rcv_accession_id":"RCV000023109","record_status":"current","interpretation_description":"risk factor","submitter_id":"3","clinical_assertion_observation_ids":["SCV000044400.0"],"variation_id":"8152","interpretation_date_last_evaluated":"2013-12-01","submission_id":"3.2014-09-05","clinical_assertion_trait_set_id":"SCV000044400","interpretation_comments":[],"local_key":"601470.0001_MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO","id":"SCV000044400","variation_archive_id":"VCV000008152","internal_id":"49656","version":"3","title":"CX3CR1, VAL249ILE/THR280MET_MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO","date_last_updated":"2019-05-18","assertion_type":"variation to included disease","trait_set_id":"6838","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000008630","record_status":"current","interpretation_description":"protective","submitter_id":"3","clinical_assertion_observation_ids":["SCV000028838.0"],"variation_id":"8152","interpretation_date_last_evaluated":"2015-05-18","submission_id":"3.2014-09-05","clinical_assertion_trait_set_id":"SCV000028838","interpretation_comments":[],"local_key":"601470.0001_CORONARY ARTERY DISEASE, RESISTANCE TO","id":"SCV000028838","variation_archive_id":"VCV000008152","internal_id":"28838","version":"3","title":"CX3CR1, VAL249ILE/THR280MET_CORONARY ARTERY DISEASE, RESISTANCE TO","date_last_updated":"2019-05-09","assertion_type":"variation to included disease","trait_set_id":"2228","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000008629","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000028837.0"],"variation_id":"8152","interpretation_date_last_evaluated":"2014-09-05","submission_id":"3.2014-09-05","clinical_assertion_trait_set_id":"SCV000028837","interpretation_comments":[],"local_key":"601470.0001_HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS","id":"SCV000028837","variation_archive_id":"VCV000008152","internal_id":"28837","version":"3","title":"CX3CR1, VAL249ILE/THR280MET_HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"2227","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2014-09-05","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500188","clinical_assertion_observation_ids":["SCV000188769.0"],"variation_id":"12610","interpretation_date_last_evaluated":"2014-02-03","submission_id":"500188.2014-08-28","clinical_assertion_trait_set_id":"SCV000188769","interpretation_comments":[],"content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_176795.3:c.173C\u003eT|MedGen:C0587248","id":"SCV000188769","variation_archive_id":"VCV000012610","internal_id":"335070","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2019-02-15","rcv_accession_id":"RCV000153516","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"25969","clinical_assertion_observation_ids":["SCV000884146.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-05-02","submission_id":"25969.2018-10-10","clinical_assertion_trait_set_id":"SCV000884146","interpretation_comments":["{\"text\":\"One copy of the c.665C\u003eT; p.Ala222Val variant, also known as C677T or thermolabile variant, was detected in the MTHFR gene by massively parallel sequencing and confirmed by Sanger sequencing. This variant is observed in the general population at an overall allele frequency of 30.8% (85329/277132 alleles, including 15447 homozygotes) in the Genome Aggregation Database. This variant has been studied extensively and is considered a ''susceptibility'' or an ''association'' variant. The thermolabile c.665C\u003eT in a homozygous state has been correlated with reduced enzyme activity and increased homocysteine (Frosst 1995). Recent publication of the American College of Medical Genetics stated that this variant, c.665C\u003eT; p.Ala222Val, in the heterozygous form is unlikely to be of clinical significance (Hickey 2013); however, a possible effect of this variant when paired with the pathogenic MTHFR variant, on the opposite chromosome cannot be excluded. Deep intronic variants and variants in the untranslated region are not analyzed by this method; therefore, another pathogenic MTHFR variant cannot be ruled out.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","local_key":"74380|Not Provided","id":"SCV000884146","variation_archive_id":"VCV000003520","internal_id":"1730401","version":"1","date_last_updated":"2019-05-27","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4618058"]}
{"date_created":"2019-03-21","rcv_accession_id":"RCV000761447","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"506653","clinical_assertion_observation_ids":["SCV000891532.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-12-30","submission_id":"506653.2018-10-25","clinical_assertion_trait_set_id":"SCV000891532","interpretation_comments":[],"content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"16432849\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_005957.4:c.665C\u003eT|OMIM:188050","id":"SCV000891532","variation_archive_id":"VCV000003520","internal_id":"1747332","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6404","review_status":"no assertion criteria provided","submission_names":["SUB4684823"]}
{"date_created":"2017-02-17","rcv_accession_id":"RCV000417131","record_status":"current","interpretation_description":"drug response","submitter_id":"500295","clinical_assertion_observation_ids":["SCV000494694.0"],"variation_id":"3520","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2018-05-14","submission_id":"500295.2018-06-18","clinical_assertion_trait_set_id":"SCV000494694","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/827848365\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\",\"@Type\":\"public\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"11418485\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12453860\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12915598\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14647408\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15781665\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16013960\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16019535\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16462575\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16463153\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16501586\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16870553\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17180579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17323057\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17488658\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17512587\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18458567\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18987660\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19648163\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21644011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21747412\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22143415\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22838948\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23089671\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23488607\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23648444\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23775025\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24241962\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24637499\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25007187\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25065700\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25110820\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25303299\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25778468\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26014925\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27399166\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28696419\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29683944\",\"@Source\":\"PubMed\"}}],\"ExplanationOfInterpretation\":{\"$\":\"Drug-variant association: Dosage, Efficacy, Toxicity/ADR\"}}}","local_key":"827848365PA450428|methotrexate response - Dosage, Efficacy, Toxicity/ADR","id":"SCV000494694","variation_archive_id":"VCV000003520","internal_id":"967913","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"35046","review_status":"reviewed by expert panel","submission_names":["PharmGKB-ClinVar 2018-05"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000003697","record_status":"current","interpretation_description":"Benign","submitter_id":"3","clinical_assertion_observation_ids":["SCV000023860.0"],"variation_id":"3520","interpretation_date_last_evaluated":"2019-06-11","submission_id":"3.2015-03-10","clinical_assertion_trait_set_id":"SCV000023860","interpretation_comments":[],"local_key":"607093.0003_MTHFR THERMOLABILE POLYMORPHISM","id":"SCV000023860","variation_archive_id":"VCV000003520","internal_id":"23860","version":"6","title":"MTHFR, 677C-T, ALA222VAL (rs1801133)_MTHFR THERMOLABILE POLYMORPHISM","date_last_updated":"2019-06-18","assertion_type":"variation to disease","trait_set_id":"916","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2015-01-28","rcv_accession_id":"RCV000153516","record_status":"current","interpretation_description":"other","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000203040.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-01-13","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000203040","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MTHFR\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"ExplanationOfInterpretation\":{\"$\":\"Variant classified as \\\"other reportable\\\" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles).\"}}}","local_key":"8162_000000","id":"SCV000203040","variation_archive_id":"VCV000003520","internal_id":"361011","version":"7","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2019-05-17","rcv_accession_id":"RCV000219296","record_status":"current","interpretation_description":"Likely benign","submitter_id":"505849","clinical_assertion_observation_ids":["SCV000910906.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-04-19","submission_id":"505849.2018-11-06","clinical_assertion_trait_set_id":"SCV000910906","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"Db4KrQBSZeoE7-orUyypkaRSy9Lm52xvIWbvYpjplzM|MedGen:C0027672","id":"SCV000910906","variation_archive_id":"VCV000037594","internal_id":"1778861","version":"1","date_last_updated":"2019-05-20","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB4721021"]}
{"date_created":"2016-05-27","rcv_accession_id":"RCV000219296","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"61756","clinical_assertion_observation_ids":["SCV000274232.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-02-19","submission_id":"61756.2016-05-09","clinical_assertion_trait_set_id":"SCV000274232","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (10/2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"a31329","id":"SCV000274232","variation_archive_id":"VCV000037594","internal_id":"510686","version":"2","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":[]}
{"date_created":"2012-11-07","rcv_accession_id":"RCV000031175","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500037","clinical_assertion_observation_ids":["SCV000053775.0"],"variation_id":"37594","interpretation_date_last_evaluated":"2008-09-04","submission_id":"500037.2012-07-24","clinical_assertion_trait_set_id":"SCV000053775","interpretation_comments":[],"local_key":"SCRP_var_219","id":"SCV000053775","variation_archive_id":"VCV000037594","internal_id":"89390","version":"3","title":"NM_007294.3:c.446A\u003eC AND Breast-ovarian cancer, familial 1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-04-13","rcv_accession_id":"RCV000458634","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500031","clinical_assertion_observation_ids":["SCV000549301.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-05-21","submission_id":"500031.2018-08-29","clinical_assertion_trait_set_id":"SCV000549301","interpretation_comments":["{\"text\":\"This sequence change replaces glutamic acid with alanine at codon 149 of the BRCA1 protein (p.Glu149Ala). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and alanine. This variant is present in population databases (rs397507233, ExAC 0.07%). This variant has been reported in individuals affected with breast cancer (PMID: 22116506, 27257965) and stomach cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 37594). Experimental studies have shown that this missense change does not impact BRCA1 homology-directed repair activity (PMID: 26689913). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Nykamp K et al. (Genet Med 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26689913\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22116506\",\"@Source\":\"PubMed\"}}]}}","local_key":"676082|MedGen:C0677776","id":"SCV000549301","variation_archive_id":"VCV000037594","internal_id":"1062197","version":"4","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"criteria provided, single submitter","submission_names":["SUB4474525"]}
{"date_created":"2017-04-24","rcv_accession_id":"RCV000479398","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000570422.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-09-25","submission_id":"26957.2019-01-29","clinical_assertion_trait_set_id":"SCV000570422","interpretation_comments":["{\"text\":\"This variant is denoted BRCA1 c.446A\u003eC at the cDNA level, p.Glu149Ala (E149A) at the protein level, and results in the change of a Glutamic Acid to an Alanine (GAA\u003eGCA). Using alternate nomenclature, this variant would be defined as BRCA1 565A\u003eC. This variant was observed in several individuals with breast cancer and in one individual with gastric cancer (Zhang 2012, Lu 2015, Zhong 2016, Wei 2018). Functional analysis of this variant showed no significant difference as compared to wild type in a homologous directed repair assay (Lu 2015). BRCA1 Glu149Ala was observed at an allele frequency of 0.06% (12/18870) in individuals of East Asian ancestry in large population cohorts (Lek 2016). This variant is located within a region that binds BRD7 (Harte 2010). Protein-based in silico analysis, which includes protein predictors and evolutionary conservation, predicts that this variant is probably damaging to protein structure and function, and splicing models are uninformative in their assessment as to whether or not the variant is damaging. Based on currently available evidence, it is unclear whether BRCA1 Glu149Ala is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:1080047|Not Provided","id":"SCV000570422","variation_archive_id":"VCV000037594","internal_id":"1105529","version":"5","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB5098196"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000326661","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000363106.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000363106","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"165026|Nonsyndromic Hearing Loss, Recessive","id":"SCV000363106","variation_archive_id":"VCV000046503","internal_id":"676628","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33370","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000381540","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000363107.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000363107","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"165026|Usher Syndrome","id":"SCV000363107","variation_archive_id":"VCV000046503","internal_id":"676629","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"2631","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000039762","record_status":"current","interpretation_description":"Likely benign","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000063451.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-09-04","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000063451","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located near a splice junction and has been identified in 0.3% (381/126618) European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs111033445).\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","local_key":"30968208|not specified","id":"SCV000063451","variation_archive_id":"VCV000046503","internal_id":"104651","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000357820","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000429634.0"],"variation_id":"48176","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000429634","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"231996|Nonsyndromic Hearing Loss, Recessive","id":"SCV000429634","variation_archive_id":"VCV000048176","internal_id":"743155","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33370","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000041467","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000065162.0"],"variation_id":"48176","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-04-25","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000065162","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosomal recessive sensorineural hearing loss who carried a second OTOF variant of uncertain significance; it is unclear whether these variants are in trans (Sommen 2016). The p.Arg544Cys variant has also been identified by our laboratory in 5 individuals with hearing loss; however, none of these individuals carried variant affecting the other copy of the OTOF gene or was reported to have auditory neuropathy typically associated with OTOF related hearing loss. This variant has been reported in ClinVar (Variation ID# 48176) as of uncertain significance. It has been identified in 0.2% (193/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs139954767); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analysis suggest that the p.Arg544Cys variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Arg544Cys variant is uncertain.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","local_key":"11832988|not specified","id":"SCV000065162","variation_archive_id":"VCV000048176","internal_id":"106362","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2019-05-23","rcv_accession_id":"RCV000778139","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000914269.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2019-04-05","submission_id":"504895.2019-04-05","clinical_assertion_trait_set_id":"SCV000914269","interpretation_comments":["{\"text\":\"Across a selection of available literature, the ABCA4 c.6148G\u003eC (p.Val2050Leu) missense variant has been reported in at least seven individuals affected with Stargardt macular degeneration including in three in a compound heterozygous state, in one in a heterozygous state and in at least three with unknown zygosity. The variant has also been reported in two brothers affected with cone-rod dystrophy in a compound heterozygous state with a frameshift variant on the second allele, and in a heterozygous state in one individual affected with macular dystrophy (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Schulz et al. 2017; Haer-Wigman et al. 2017). The variant failed to segregate with the disorder in one family affected with autosomal recessive retinitis pigmentosa and in one with autosomal dominant macular dystrophy (Wiszniewski et al. 2005; Poloschek et al. 2010). The p.Val2050Leu variant has also been found as a complex allele in cis with either a stop-gained variant or a missense variant in individuals affected with ABCA4-related disorders (Sciezynska et al. 2016; Schulz et al. 2017). The variant was found in a heterozygous state in one of 1528 control individuals and in one unaffected parent (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Sciezynska et al. 2016). This variant is reported at a frequency of 0.028846 in Puerto Ricans from Puerto Rico from the 1000 Genomes Project and in one homozygote in the European (non-Finnish) population of the Genome Aggregation Database. Poloschek et al. (2010) showed that, upon ophthalmic examination, heterozygous carriers of the p.Val2050Leu variant display centrally reduced mfERG amplitudes and additional minor fundus abnormalities, suggesting that the p.Val2050Leu variant is capable of mildly reducing macular function in the heterozygous state without an additional pathogenic variant on the second allele. Based on the collective evidence the p.Val2050Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for ABCA4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/d4q7wshq/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26593885\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973280\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28224992\",\"@Source\":\"PubMed\"}}]}}","local_key":"909158","id":"SCV000914269","variation_archive_id":"VCV000007884","internal_id":"1789326","version":"1","date_last_updated":"2019-05-27","assertion_type":"variation to disease","trait_set_id":"33431","review_status":"criteria provided, single submitter","submission_names":["SUB5424092"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000285333","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359224.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359224","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Cone-Rod Dystrophy, Recessive","id":"SCV000359224","variation_archive_id":"VCV000007884","internal_id":"672746","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33383","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000008335","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000028543.0"],"variation_id":"7884","interpretation_date_last_evaluated":"2016-12-29","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000028543","interpretation_comments":[],"local_key":"601691.0005_STARGARDT DISEASE 1","id":"SCV000028543","variation_archive_id":"VCV000007884","internal_id":"28543","version":"3","title":"ABCA4, VAL2050LEU_STARGARDT DISEASE 1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1448","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2014-01-16","rcv_accession_id":"RCV000259072","record_status":"current","interpretation_description":"Benign","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000110530.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-11-17","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000110530","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCA4\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?chr=1\u0026from=94467548\u0026to=94467548\"}}]}}","local_key":"11450_000000","id":"SCV000110530","variation_archive_id":"VCV000007884","internal_id":"192622","version":"8","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000433779","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504293.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504293","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D018268","id":"SCV000504293","variation_archive_id":"VCV000013972","internal_id":"969569","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"35132","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000443882","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504291.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504291","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19537845\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22310681\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12068308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25157968\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20619739\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21129611\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20350999\",\"@Source\":\"PubMed\"}}]},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D015179","id":"SCV000504291","variation_archive_id":"VCV000013972","internal_id":"969567","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"31428","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000437006","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504296.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504296","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MedGen:C0279680","id":"SCV000504296","variation_archive_id":"VCV000013972","internal_id":"969572","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"35142","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000442759","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504297.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-31","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504297","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D009101","id":"SCV000504297","variation_archive_id":"VCV000013972","internal_id":"969573","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6478","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000426339","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000504295.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-07-14","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000504295","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14679157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18794803\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12068308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25157968\",\"@Source\":\"PubMed\"}}]},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D008545","id":"SCV000504295","variation_archive_id":"VCV000013972","internal_id":"969571","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"12074","review_status":"no assertion criteria provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000037932","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000061597.0"],"variation_id":"13972","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2012-06-11","submission_id":"21766.2016-04-26","clinical_assertion_trait_set_id":"SCV000061597","interpretation_comments":["{\"text\":\"This variant has been reported as a somatic change in large intestine, skin, endometrium, stomach, and ovary (COSMIC, Fransen 2004) and has been observed in up to 11% of BRAF mutant positive lung adenocarcinoma (Paik 2011).\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"14688025\",\"@Source\":\"PubMed\"}}}}","local_key":"15072993|MedGen:C0007131","id":"SCV000061597","variation_archive_id":"VCV000013972","internal_id":"102797","version":"4","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"4069","review_status":"criteria provided, single submitter","submission_names":["LMM_All_April_2016","LMM_all.variants_NCBI_3.16.2013"]}
{"date_created":"2018-09-20","rcv_accession_id":"RCV000680453","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"1024","clinical_assertion_observation_ids":["SCV000807826.0"],"variation_id":"822","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2018-06-01","submission_id":"1024.2018-07-17","clinical_assertion_trait_set_id":"SCV000807826","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"APC-B1|MedGen:CN240755","id":"SCV000807826","variation_archive_id":"VCV000000822","internal_id":"1575248","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"35108","review_status":"criteria provided, single submitter","submission_names":["SUB4304907"]}
{"date_created":"2018-09-12","rcv_accession_id":"RCV000034388","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"239772","clinical_assertion_observation_ids":["SCV000805404.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-01-06","submission_id":"239772.2018-01-29","clinical_assertion_trait_set_id":"SCV000805404","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000038.5:c.3920T\u003eA|not provided","id":"SCV000805404","variation_archive_id":"VCV000000822","internal_id":"1570355","version":"1","date_last_updated":"2019-06-26","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB3589995"]}
{"date_created":"2017-09-27","rcv_accession_id":"RCV000120049","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500110","clinical_assertion_observation_ids":["SCV000600091.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-02-08","submission_id":"500110.2017-08-01","clinical_assertion_trait_set_id":"SCV000600091","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest pathogenicity assessment criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16875934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12533824\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135136\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_000038.5:c.3920T\u003eA|not provided","id":"SCV000600091","variation_archive_id":"VCV000000822","internal_id":"1163765","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB2915479"]}
{"date_created":"2014-06-09","rcv_accession_id":"RCV000120049","record_status":"current","interpretation_description":"not provided","submitter_id":"504914","clinical_assertion_observation_ids":["SCV000084184.0","SCV000084184.1","SCV000084184.2","SCV000084184.3","SCV000084184.4","SCV000084184.5","SCV000084184.6"],"variation_id":"822","interpretation_date_last_evaluated":"2013-09-19","submission_id":"504914.2014-05-29","clinical_assertion_trait_set_id":"SCV000084184","interpretation_comments":[],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},\"Comment\":{\"$\":\"Please see associated publication for description of ethnicities\",\"@Type\":\"public\"}}","local_key":"MedGen:CN169374","id":"SCV000084184","variation_archive_id":"VCV000000822","internal_id":"281153","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"no assertion provided","submission_names":["Cancer_genes_01"]}
{"date_created":"2017-11-02","rcv_accession_id":"RCV000034388","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"505698","clinical_assertion_observation_ids":["SCV000610138.0"],"variation_id":"822","interpretation_date_last_evaluated":"2017-07-27","submission_id":"505698.2017-10-05","clinical_assertion_trait_set_id":"SCV000610138","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"19388615","id":"SCV000610138","variation_archive_id":"VCV000000822","internal_id":"1190191","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":[]}
{"date_created":"2019-02-15","rcv_accession_id":"RCV000020088","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"506039","clinical_assertion_observation_ids":["SCV000883121.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-11-21","submission_id":"506039.2018-11-26","clinical_assertion_trait_set_id":"SCV000883121","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","id":"SCV000883121","variation_archive_id":"VCV000000822","internal_id":"1729239","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"criteria provided, single submitter","submission_names":["SUB4842992"]}
{"date_created":"2017-08-25","rcv_accession_id":"RCV000120049","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"506152","clinical_assertion_observation_ids":["SCV000591159.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-08-15","submission_id":"506152.2017-04-19","clinical_assertion_trait_set_id":"SCV000591159","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16140997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19047896\",\"@Source\":\"PubMed\"}}]},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","local_key":"NM_000038.5:c.3920T\u003eA|not specified","id":"SCV000591159","variation_archive_id":"VCV000000822","internal_id":"1147603","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SHS20170111"]}
{"date_created":"2018-11-21","rcv_accession_id":"RCV000722046","record_status":"current","interpretation_description":"risk factor","submitter_id":"506211","clinical_assertion_observation_ids":["SCV000853088.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-01-01","submission_id":"506211.2018-10-29","clinical_assertion_trait_set_id":"SCV000853088","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0699790","id":"SCV000853088","variation_archive_id":"VCV000000822","internal_id":"1663716","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"1735","review_status":"criteria provided, single submitter","submission_names":["SUB4705375"]}
{"date_created":"2018-03-01","rcv_accession_id":"RCV000115087","record_status":"current","interpretation_description":"risk factor","submitter_id":"506273","clinical_assertion_observation_ids":["SCV000693480.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-11-10","submission_id":"506273.2017-11-15","clinical_assertion_trait_set_id":"SCV000693480","interpretation_comments":[],"local_key":"CCDS4107.1:c.3920T\u003eA|Hereditary cancer-predisposing syndrome","id":"SCV000693480","variation_archive_id":"VCV000000822","internal_id":"1359177","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"no assertion criteria provided","submission_names":["SUB3222006"]}
{"date_created":"2016-07-29","rcv_accession_id":"RCV000238802","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"165021","clinical_assertion_observation_ids":["SCV000297021.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-11-24","submission_id":"165021.2016-01-06","clinical_assertion_trait_set_id":"SCV000297021","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"DGD Variant Analysis Guidelines\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"DGD_Variant_Analysis_Guidelines.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx\"}}},\"StudyDescription\":{\"$\":\"Clinical exome data\"}}","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0032580","id":"SCV000297021","variation_archive_id":"VCV000000822","internal_id":"574598","version":"2","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"8942","review_status":"criteria provided, single submitter","submission_names":["exome2015-12-22"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000000865","record_status":"current","interpretation_description":"risk factor","submitter_id":"3","clinical_assertion_observation_ids":["SCV000021015.0"],"variation_id":"822","interpretation_date_last_evaluated":"2003-12-01","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000021015","interpretation_comments":[],"local_key":"611731.0029_BREAST CANCER, SUSCEPTIBILITY TO","id":"SCV000021015","variation_archive_id":"VCV000000822","internal_id":"21015","version":"3","title":"APC, ILE1307LYS_BREAST CANCER, SUSCEPTIBILITY TO","date_last_updated":"2019-05-02","assertion_type":"variation to included disease","trait_set_id":"216","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2014-05-13","rcv_accession_id":"RCV000034388","record_status":"current","interpretation_description":"risk factor","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000148996.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-05-08","submission_id":"26957.2018-09-07","clinical_assertion_trait_set_id":"SCV000148996","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification(06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:3786|Not Provided","id":"SCV000148996","variation_archive_id":"VCV000000822","internal_id":"269650","version":"4","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4498316"]}
{"date_created":"2014-06-03","rcv_accession_id":"RCV000020088","record_status":"current","interpretation_description":"risk factor","submitter_id":"500031","clinical_assertion_observation_ids":["SCV000153895.0"],"variation_id":"822","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-01-13","submission_id":"500031.2018-04-02","clinical_assertion_trait_set_id":"SCV000153895","interpretation_comments":["{\"text\":\"This sequence change replaces isoleucine with lysine at codon 1307 of the APC protein (p.Ile1307Lys). The isoleucine residue is weakly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is present in population databases (rs1801155, ExAC 0.3%). This variant is found in ~10% of Ashkenazi Jewish individuals and ~3% of Sephardic Jewish individuals (PMID: 23896379). Other studies have reported a 6-7% frequency in Ashkenazi individuals (PMID: 9288102). This variant is found in ~28% of Ashkenazi Jewish individuals with familial colorectal cancer (PMID: 9288102). ClinVar contains an entry for this variant (Variation ID: 822). In a large meta-analysis involving ~10,000 cases and controls (PMID: 23576677), Ashkenazi Jewish individuals who carried the I1307K change had a significantly increased risk of colorectal cancer (OR=2.17, 95% CI=1.65-2.86). By contrast, the I1307K change did not appear to confer any additional risk of colorectal cancer in non-Ashkenazi Jewish individuals (OR=1.36, 95% CI=0.59-3.13). This DNA substitution converts an AAATAAAA sequence element into an extended tract of eight adenosine nucleotides (A8). The A8 mononucleotide tract created by this change has been shown to confer an increased propensity for somatic truncating mutations on this allele (PMID: 9751605). In summary, this is a frequently observed variant that is associated with a 2-fold increased risk of colorectal cancer in the Ashkenazi Jewish population. An increased risk of colorectal cancer in individuals who are not of Ashkenazi Jewish ancestry has not been established.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Nykamp K et al. (Genet Med 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}}]}}","local_key":"7840|MedGen:C2713442","id":"SCV000153895","variation_archive_id":"VCV000000822","internal_id":"279290","version":"8","date_last_updated":"2019-05-02","assertion_type":"variation to disease","trait_set_id":"6265","review_status":"criteria provided, single submitter","submission_names":["SUB3864685"]}
{"date_created":"2015-09-12","rcv_accession_id":"RCV000190782","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"61756","clinical_assertion_observation_ids":["SCV000244223.0"],"variation_id":"208761","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-04-08","submission_id":"61756.2018-02-08","clinical_assertion_trait_set_id":"SCV000244223","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: POSITIVE: Relevant Alteration(s) Detected\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ambry_reporting_categories_2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/r82hsyqe/ambry_reporting_categories_2017.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9430594\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10323247\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22169383\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10781098\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12742592\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15608631\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14985406\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23849776\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"6965523\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9425895\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20196795\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24107868\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8327138\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11572947\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17872363\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17675531\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16829045\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22926866\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23621294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18238816\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24318194\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26795593\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26993267\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25982755\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27861786\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27602407\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22275249\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28602030\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29129156\",\"@Source\":\"PubMed\"}}]}}","local_key":"a71637G","id":"SCV000244223","variation_archive_id":"VCV000208761","internal_id":"454676","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"25797","review_status":"criteria provided, single submitter","submission_names":["exome clinvar deposit 2.18.18"]}
{"date_created":"2018-12-20","rcv_accession_id":"RCV000735453","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500086","clinical_assertion_observation_ids":["SCV000863590.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2010-07-08","submission_id":"500086.2018-07-18","clinical_assertion_trait_set_id":"SCV000863590","interpretation_comments":[],"content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN221562","id":"SCV000863590","variation_archive_id":"VCV000017674","internal_id":"1688796","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"20192","review_status":"no assertion criteria provided","submission_names":["SUB4310295"]}
{"date_created":"2016-06-24","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"504863","clinical_assertion_observation_ids":["SCV000282322.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-04-22","submission_id":"504863.2016-06-09","clinical_assertion_trait_set_id":"SCV000282322","interpretation_comments":["{\"text\":\"Variant allele predicted to encode a truncated non-functional protein.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf\"}}},\"StudyDescription\":{\"$\":\"ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/\"}}","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","id":"SCV000282322","variation_archive_id":"VCV000017674","internal_id":"537053","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"reviewed by expert panel","submission_names":["ENIGMA_2015-08-17"]}
{"date_created":"2017-05-25","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505214","clinical_assertion_observation_ids":["SCV000577930.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-01-01","submission_id":"505214.2017-03-15","clinical_assertion_trait_set_id":"SCV000577930","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"GNL0017|OMIM:604370","id":"SCV000577930","variation_archive_id":"VCV000017674","internal_id":"1125848","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"criteria provided, single submitter","submission_names":["BRCA_Malaga"]}
{"date_created":"2017-04-21","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505260","clinical_assertion_observation_ids":["SCV000564378.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-11-20","submission_id":"505260.2017-04-17","clinical_assertion_trait_set_id":"SCV000564378","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_007294.3:c.4065_4068del|MedGen:C2676676","id":"SCV000564378","variation_archive_id":"VCV000017674","internal_id":"1099012","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"criteria provided, single submitter","submission_names":[]}
{"date_created":"2018-02-15","rcv_accession_id":"RCV000131887","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505849","clinical_assertion_observation_ids":["SCV000683147.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-04-13","submission_id":"505849.2017-10-26","clinical_assertion_trait_set_id":"SCV000683147","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"Db4KrQBSZeoE7-orUyypkQ9ffftxzNCEBpQllhdTwYY|MedGen:C0027672","id":"SCV000683147","variation_archive_id":"VCV000017674","internal_id":"1338690","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB3163908"]}
{"date_created":"2017-08-04","rcv_accession_id":"RCV000048431","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506247","clinical_assertion_observation_ids":["SCV000587372.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2014-01-31","submission_id":"506247.2017-08-04","clinical_assertion_trait_set_id":"SCV000587372","interpretation_comments":[],"content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","local_key":"286798|Orphanet:ORPHA145","id":"SCV000587372","variation_archive_id":"VCV000017674","internal_id":"1140299","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"7920","review_status":"no assertion criteria provided","submission_names":["RMGL-WCRI-05152017"]}
{"date_created":"2018-04-06","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506382","clinical_assertion_observation_ids":["SCV000733615.0"],"variation_id":"17674","submitted_assembly":"GRCh37","submission_id":"506382.2018-04-04","clinical_assertion_trait_set_id":"SCV000733615","interpretation_comments":[],"content":"{\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","id":"SCV000733615","variation_archive_id":"VCV000017674","internal_id":"1414776","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"no assertion criteria provided","submission_names":["SUB3868021"]}
{"date_created":"2016-07-29","rcv_accession_id":"RCV000159924","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500110","clinical_assertion_observation_ids":["SCV000296305.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-03-02","submission_id":"500110.2018-08-31","clinical_assertion_trait_set_id":"SCV000296305","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest pathogenicity assessment criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26295337\",\"@Source\":\"PubMed\"}}}","local_key":"2420169|not provided","id":"SCV000296305","variation_archive_id":"VCV000017674","internal_id":"573876","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4481696"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000019243","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000039531.0"],"variation_id":"17674","interpretation_date_last_evaluated":"1994-12-01","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000039531","interpretation_comments":[],"local_key":"113705.0015_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","id":"SCV000039531","variation_archive_id":"VCV000017674","internal_id":"39531","version":"4","title":"BRCA1, 4-BP DEL, 4185TCAA_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1917","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2014-08-01","rcv_accession_id":"RCV000131887","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"61756","clinical_assertion_observation_ids":["SCV000186942.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-03-15","submission_id":"61756.2018-07-30","clinical_assertion_trait_set_id":"SCV000186942","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/10Jq49tz/AD_XL_ClassificationScheme_03.2017_Ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"7837387\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16455195\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17100994\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24504028\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27553291\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28831036\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28724667\",\"@Source\":\"PubMed\"}}]}}","local_key":"a89762","id":"SCV000186942","variation_archive_id":"VCV000017674","internal_id":"305457","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB4348735"]}
{"date_created":"2015-02-19","rcv_accession_id":"RCV000159924","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000210049.0"],"variation_id":"17674","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-12-19","submission_id":"26957.2019-01-29","clinical_assertion_trait_set_id":"SCV000210049","interpretation_comments":["{\"text\":\"This deletion of four nucleotides in BRCA1 is denoted c.4065_4068delTCAA at the cDNA level and p.Asn1355LysfsX10 (N1355KfsX10) at the protein level. The normal sequence, with the bases that are deleted in brackets, is ATAA[delTCAA]GAAG. The deletion causes a frameshift, which changes an Asparagine to a Lysine at codon 1355, and creates a premature stop codon at position 10 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant, also reported as BRCA1 4184del4 or 4184_4187delTCAA using alternate nomenclature, has been reported in association with hereditary breast cancer and in multiple individuals with breast, ovarian, or prostate cancer (Friedman 1994, Neuhausen 1996, Liede 2002, Meindl 2002, Farooq 2011, Couch 2015, Bu 2016, Chan 2018). We consider this variant to be pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:7571|Not Provided","id":"SCV000210049","variation_archive_id":"VCV000017674","internal_id":"375724","version":"13","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB5098196"]}
{"date_created":"2017-01-26","rcv_accession_id":"RCV000416302","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"505789","clinical_assertion_observation_ids":["SCV000494066.0"],"variation_id":"424841","submitted_assembly":"GRCh37","submission_id":"505789.2016-12-30","clinical_assertion_trait_set_id":"SCV000494066","interpretation_comments":["{\"text\":\"In this patient identified as compound heterozygous variants NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT].\",\"type\":\"public\"}"],"content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27884168\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT]|OMIM:208900","id":"SCV000494066","variation_archive_id":"VCV000424841","internal_id":"966237","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"770","review_status":"no assertion criteria provided","submission_names":["Ataxia_Telangiectasia"]}
{"date_created":"2011-01-25","rcv_accession_id":"RCV000008060","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000028265.0"],"variation_id":"7621","interpretation_date_last_evaluated":"1998-06-01","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000028265","interpretation_comments":[],"local_key":"601920.0007_ALAGILLE SYNDROME 1","id":"SCV000028265","variation_archive_id":"VCV000007621","internal_id":"28265","version":"1","title":"JAG1, 5-BP DEL_ALAGILLE SYNDROME 1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"2076","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-12-28","rcv_accession_id":"RCV000567707","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"61756","clinical_assertion_observation_ids":["SCV000665087.0"],"variation_id":"481015","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-05-16","submission_id":"61756.2018-07-30","clinical_assertion_trait_set_id":"SCV000665087","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: In silico models in agreement (deleterious) and/or completely conserved position in appropriate species\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (10/2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"a626669","id":"SCV000665087","variation_archive_id":"VCV000481015","internal_id":"1300505","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"13598","review_status":"criteria provided, single submitter","submission_names":["SUB4348735"]}
{"date_created":"2017-12-14","rcv_accession_id":"RCV000223898","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"1012","clinical_assertion_observation_ids":["SCV000614141.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-12-16","submission_id":"1012.2017-08-17","clinical_assertion_trait_set_id":"SCV000614141","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25637381\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23299917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24055113\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_000256.3:c.1504C\u003eT|not provided","id":"SCV000614141","variation_archive_id":"VCV000042540","internal_id":"1197795","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB2963629"]}
{"date_created":"2018-03-15","rcv_accession_id":"RCV000252398","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500026","clinical_assertion_observation_ids":["SCV000696313.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-07-26","submission_id":"500026.2018-01-25","clinical_assertion_trait_set_id":"SCV000696313","interpretation_comments":["{\"text\":\"Variant summary: The MYBPC3 c.1504C\u003eT (p.Arg502Trp) variant involves the alteration of a conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 3/122664 control chromosomes at a frequency of 0.0000245, which does not exceed the estimated maximal expected allele frequency of a pathogenic MYBPC3 variant (0.0010005). This variant has been reported in numerous HCM patients, with evidence of co-segregation of variant with disease in some of the families. Structure study predicted the R502W mutation and other HCM-linked mutations found within the same C3 domain, may directly disrupt the interaction of cMyBP-C with other sarcomeric proteins (Zhang_2014). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. It is the most common pathogenic HCM variant identified by our laboratory. Taken together, this variant is classified as pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18409188\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15115610\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15166115\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19293840\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18403758\",\"@Source\":\"PubMed\"}}]}}","local_key":"NM_000256.3:c.1504C\u003eT|MedGen:CN230736","id":"SCV000696313","variation_archive_id":"VCV000042540","internal_id":"1362665","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"32616","review_status":"criteria provided, single submitter","submission_names":["2016-2017-variants"]}
{"date_created":"2018-10-11","rcv_accession_id":"RCV000677196","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500199","clinical_assertion_observation_ids":["SCV000840016.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-05-11","submission_id":"500199.2018-06-14","clinical_assertion_trait_set_id":"SCV000840016","interpretation_comments":["{\"text\":\"This c.1504C\u003eT (p.Arg502Trp) variant has been reported in multiple patients with hypertrophic cardiomyopathy (HCM) [PMID 1270723, 22589294, 23396983, 20378854, 23642604]. The variant was detected in 34 individuals from a large study of 1,414 unrelated HCM patients [PMID 20378854]. From this study, it was estimated that this variant conveys a 340-fold increased risk for HCM by 45 years and the clinical prognosis worsens when this c.1504C\u003eT (p.Arg502Trp) change occurs in the setting of a pathogenic variant in another sarcomere protein gene [PMID 20378854]. This variant is common among HCM patients, occurring in an estimated 2.4% of patients [PMID 20378854]. This variant was reported in 3 heterozygous individuals in the ExAC database (http://exac.broadinstitute.org/variant/11-47364249-G-A). Arginine at position 502 of the MYBPC3 protein is highly conserved in mammals. While not validated for clinical use, computer-based algorithms predict this p.Arg502Trp change to be deleterious. This variant is thus classified as pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_000256.3:c.1504C\u003eT|OMIM:115197","id":"SCV000840016","variation_archive_id":"VCV000042540","internal_id":"1637569","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"2365","review_status":"criteria provided, single submitter","submission_names":["SUB4151980"]}
{"date_created":"2014-12-04","rcv_accession_id":"RCV000035406","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505295","clinical_assertion_observation_ids":["SCV000190379.0"],"variation_id":"42540","interpretation_date_last_evaluated":"2014-06-01","submission_id":"505295.2014-08-28","clinical_assertion_trait_set_id":"SCV000190379","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},\"Comment\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyDescription\":{\"$\":\"Variants classified for the Actionable exomic incidental findings in 6503 participants: challenges of variant classification manuscript\"},\"StudyName\":{\"$\":\"ESP 6500 variant annotation\"}}","local_key":"UWMG_1586863","id":"SCV000190379","variation_archive_id":"VCV000042540","internal_id":"347842","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"2675","review_status":"no assertion criteria provided","submission_names":["ESP 6500 variant annotation"]}
{"date_created":"2018-08-10","rcv_accession_id":"RCV000677196","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"505530","clinical_assertion_observation_ids":["SCV000803346.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-02-27","submission_id":"505530.2018-06-26","clinical_assertion_trait_set_id":"SCV000803346","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"StudyName\":{\"$\":\"AGHI-GT-HudsonAlpha\"}}","local_key":"11:47364249:C_1","id":"SCV000803346","variation_archive_id":"VCV000042540","internal_id":"1566231","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"2365","review_status":"criteria provided, single submitter","submission_names":["SUB4208489"]}
{"date_created":"2017-10-13","rcv_accession_id":"RCV000203913","record_status":"current","interpretation_description":"not provided","submitter_id":"506185","clinical_assertion_observation_ids":["SCV000606931.0"],"variation_id":"42540","submitted_assembly":"GRCh37","submission_id":"506185.2017-08-22","clinical_assertion_trait_set_id":"SCV000606931","interpretation_comments":["{\"text\":\"GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.\",\"type\":\"public\"}"],"content":"{\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"genomeconnect_15537_623","id":"SCV000606931","variation_archive_id":"VCV000042540","internal_id":"1174093","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"17368","review_status":"no assertion provided","submission_names":["GenomeConnect_hg19_81817"]}
{"date_created":"2017-09-27","rcv_accession_id":"RCV000223898","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"25969","clinical_assertion_observation_ids":["SCV000604327.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-06-22","submission_id":"25969.2018-10-10","clinical_assertion_trait_set_id":"SCV000604327","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant (rs375882485) is a well-known causative variant reported in multiple individuals with hypertrophic cardiomyopathy (HCM; Richard 2003, Maron 2008, Kaski 2012, and Lopez 2013), and shown to segregate with disease in at least one affected family (Camuglia 2013). In one large study, the p.Arg502Trp variant was identified in 2.4% of Caucasian HCM patients (Saltzman 2010). Nuclear magnetic resonance studies indicate that p.Arg502Trp may impair important electrostatic interactions between MYBPC3 protein and other sarcomeric proteins (Zhang 2014). Thus, the p.Arg502Trp variant meets our criteria for classification as pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","local_key":"118047|Not Provided","id":"SCV000604327","variation_archive_id":"VCV000042540","internal_id":"1168023","version":"2","date_last_updated":"2019-05-27","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4618058"]}
{"date_created":"2016-09-29","rcv_accession_id":"RCV000252398","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"61756","clinical_assertion_observation_ids":["SCV000319017.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-05-24","submission_id":"61756.2018-07-30","clinical_assertion_trait_set_id":"SCV000319017","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: Rarity in general population databases (dbsnp, esp, 1000 genomes),In silico models in agreement (deleterious) and/or completely conserved position in appropriate species,Deficient protein function in appropriate functional assay(s),Other strong data supporting pathogenic classification,Strong segregation with disease (lod \u003e3 = \u003e10 meioses),Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation,Well-characterized mutation at same position\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/10Jq49tz/AD_XL_ClassificationScheme_03.2017_Ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23299917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22589294\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24055113\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24111713\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23642604\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25058872\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25351510\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24793961\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27831900\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25637381\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25335496\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28166811\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27247418\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28201496\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28518168\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27532257\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27000522\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28420666\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26090888\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9562578\",\"@Source\":\"PubMed\"}}]}}","local_key":"a83323c","id":"SCV000319017","variation_archive_id":"VCV000042540","internal_id":"600711","version":"4","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"32616","review_status":"criteria provided, single submitter","submission_names":["SUB4348735"]}
{"date_created":"2016-01-29","rcv_accession_id":"RCV000203913","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"500031","clinical_assertion_observation_ids":["SCV000260968.0"],"variation_id":"42540","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-06-28","submission_id":"500031.2018-08-29","clinical_assertion_trait_set_id":"SCV000260968","interpretation_comments":["{\"text\":\"This sequence change replaces arginine with tryptophan at codon 502 of the MYBPC3 protein (p.Arg502Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs375882485, ExAC 0.01%). This variant has been shown to segregate with hypertrophic cardiomyopathy in more than ten families in the literature, and has been observed in many unrelated hypertrophic cardiomyopathy patients across multiple studies (PMID: 12707239, 20378854, 22267749, 23396983). ClinVar contains an entry for this variant (Variation ID: 42540). A different missense substitution at this codon (p.Arg502Gln) has been reported to segregate with disease in families affected with hypertrophic cardiomyopathy (PMID: 9562578, 22386539). This indicates that the Arg502 residue is important for MYBPC3 protein function. For these reasons, this variant has been classified as Pathogenic.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Nykamp K et al. (Genet Med 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23396983\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22386539\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22267749\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9562578\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}}]}}","local_key":"78346|MedGen:C0007194","id":"SCV000260968","variation_archive_id":"VCV000042540","internal_id":"485953","version":"6","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"17368","review_status":"criteria provided, single submitter","submission_names":["SUB4474525"]}
